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Abstract
Background: Primary ovarian ectopic pregnancy is a rare type of ectopic pregnancy which has an estimated
prevalence ranging from 1:7000 to 1:70,000 accounting for almost 3 % of all ectopic cases. Here we report the
case of a 25-year-old woman who presented to our clinic with abdominal pain, 6 weeks’ delay of menstruation and
3 days of vaginal bleeding, whose transvaginal ultrasonography showed an ectopic gestational sac with yolk sac
inside, in her right ovary. This case shows that early diagnosis is very important particularly in places like the
Sub-Saharan region of Africa.
Case presentation: A 25-year-old African woman was referred to our clinic with 6 weeks’ delay of menstruation,
frequent increasing abdominal pain and 3 days of vaginal bleeding. Her general condition was good and her vital
signs were normal. She felt tenderness in an abdominal examination and had a small amount of vaginal bleeding.
Transvaginal ultrasonography showed an ectopic gestational sac with yolk sac inside, in her right ovary. Our final
diagnosis was ectopic ovarian pregnancy and we successfully treated her with methotrexate. After 3 weeks of
methotrexate administration her beta human chorionic gonadotropin was negative and a sonographic examination
was completely normal.
Conclusions: Ectopic ovarian pregnancy is a very important medical situation. It should be diagnosed in its early
stages otherwise it could be life-threatening and surgical treatment may be inevitable. Because of the importance
of fertility, medical treatment is an acceptable option and can be feasible with early diagnosis.
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Background
Primary ovarian ectopic pregnancy is a rare type of
ectopic pregnancy which has an estimated prevalence
ranging from 1:7000 to 1:70,000 accounting for almost
3 % of all ectopic cases [1]. It is usually terminated by a
rupture in the first trimester and because of the
increased vascularization of the ovarian tissue it leads to
internal hemorrhage and hypovolemic shock status. The
diagnosis is usually made by emergency laparotomies
and histopathologic assessment.
Diagnosis is made using the Spiegelberg criteria [2]
which include:
a. The gestational sac is located in the region of the
ovary.
b. The ectopic pregnancy is attached to the uterus by
the ovarian ligament.
c. Ovarian tissue in the wall of the gestational sac is
proved histologically.
d. The tube on the involved side is intact.
Non-tubal pregnancies are the most common type of
ectopic pregnancy and ovarian pregnancies are the
second most common type; ovarian pregnancies are very
common with intrauterine devices (IUDs). Surgical
treatments are often performed in these cases because of
the late onset of clinical symptoms which leads to late
diagnosis [1, 2]. Methotrexate (MTX) treatment can be
used for patients in the early phases if their condition is
stable.
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Case presentation
A 25-year-old African obese woman with a history of
two cesarean sections was referred to our clinic with
6 weeks’ delay of menstruation, frequent increasing ab-
dominal pain and 3 days of vaginal bleeding. She had a
regular menstrual period before the symptoms. In her
medical history there was no record of use of an IUD,
endometriosis or pelvic inflammatory disease. This was
her third spontaneous pregnancy and there was no abor-
tion. Her general condition was good and her vital signs
were normal: blood pressure 110/70 mmHg, pulse 70
beats per minute (bpm), temperature 36.5 °C. A physical
examination showed minimal tenderness in all sides of
her abdomen with an increase in right lower pelvic sec-
tion. A speculum examination showed a small amount
of cervical bleeding, a palpable mass in rectouterine cav-
ity and increased temperature and tenderness at right
adnexial region. Transvaginal ultrasonography (USG)
showed empty uterine cavity with 11 mm thickness.
However, her rectouterine cavity was observed to be
filled with heterogenous liquid including septations and
hyperechogenic areas which were thought to be a coagu-
lum. An ectopic gestational sac and yolk sac seemed to
be inside her right ovary, and were identified close to
the midline, which correlated with her 6 weeks’ delay of
menstruation (Fig. 1). The fetus and fetal heart beat were
not clearly seen. Vascular proliferation called ‘ring of fire’
which is typical for ectopic ovarian pregnancy was de-
tected around the gestational sac (Fig. 1). Her left ovary
and tubal structures seemed to be normal. She declared
her previous menstrual periods were regular but that her
last period was 2 months ago. Laboratory analysis
showed a white blood cell count (WBC) of 11,600/mm3,
red blood cell count (RBC) of 400000/mm3, hemoglobin
(Hb) of 12.3 g/dl, hematocrit (Htc) of 36 %, beta human
chorionic gonadotropin (HCG) of 6580 and normal
urine results. She was diagnosed as having an ectopic
ovarian pregnancy and was hospitalized. She and her
family were informed about the stability of the condition
and in view of her history of two previous cesarean sec-
tions, medical treatment of MTX was planned. A single
dose of 90 mg intramuscular MTX was administered.
She was stable. A progressive decrease in her beta HCG
levels (4310 at fourth day, 2190 at seventh day, 210 at
14th day) as well as a diminishing of intraabdominal li-
quid and significant regression of her right ovarian sac
were observed and she was discharged with weekly beta
HCG test control advice. At the third week after the
MTX treatment her beta HCG level was below 5 and
her intraabdominal fluid had nearly disappeared (Fig. 2).
Discussion
The history of ectopic pregnancy is as old as humanity. The
first successful operation for ectopic pregnancy took place
Fig. 1 Ultrasound images of ovarian gestational sac before medical
methotrexate therapy. (a) Ovarian gestational sac (b) Colour doppler
image of gestational sac
Fig. 2 Control ultrasonographic image after the methotrexate
treatment
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in 1759 in the USA but the usual treatment was still medical
up to the 1800s with a maternal mortality rate reaching up
to 60 % [3]. The high mortality rates drew special atten-
tion which led to crucial developments in the diagno-
sis and treatment of this condition. Salpingectomy,
which started to be performed from the 1800s, is ob-
served to be lifesaving because it decreased the ma-
ternal mortality rates to nearly 5 %.
Ovarian ectopic pregnancy is a rare variant of ectopic
pregnancy [4]. It occurs by fertilization of an ovum
retained in the peritoneal cavity leading to implantation
on the ovarian surface [5]. Women with ovarian ectopic
pregnancies usually present with lower abdominal pain,
menstrual irregularities as in other ectopic conditions
and corpus luteum cyst. Although early diagnosis and
early treatment are crucial, preoperative and sometimes
intraoperative diagnoses are difficult. Diagnosis is usually
made by pathological assessment and therefore the Spie-
gelberg criteria are very important for the diagnosis of
ectopic ovarian pregnancy [6].
Prediagnosis is usually supported by increased beta
HCG levels. The current data inform that most cases
occur in the first trimester. Early onset rupture can lead
to massive intraabdominal hemorrhage resulting in
hypovolemia which can be life-threatening. Some rare
cases that reach second trimester are also documented
[7]. There are also published cases of twin ovarian ec-
topic pregnancies and coincidence of uterine and ovar-
ian ectopic pregnancies [7–10]. We also found some
articles on ectopic pregnancies of advanced gestational
age diagnosed preoperatively with USG and magnetic
resonance imaging (MRI) [7, 11]. In the study of Hallat,
a preoperative diagnosis was achieved in 28 % of 25
primary ectopic pregnancy cases. All other cases were
diagnosed by pathological assessment postoperatively
[12]. Phupong and Ultchaswadi declared that the evalu-
ation of beta HCG together with transvaginal USG can
be helpful for early diagnosis [13].
The cause of implantation anomalies in ovarian
ectopic pregnancy is not clear [7, 12, 13]. There are vari-
ous hypotheses such as:
a. Delay of ovum liberation.
b. Thickening of tunica albuginea.
c. Tubal dysfunction.
d. Intrauterine contraception devices (for example, IUDs).
Pelvic inflammatory disease does not have an effect on
ovarian ectopic pregnancy like it does on tubal pregnancy
[9, 14]. IUDs are thought to be a main factor in ovarian ec-
topic pregnancy cases according to the majority of studies.
It is believed that IUDs trigger mild inflammation that dis-
turbs the ciliary activity of the endosalpinx and leads to
ovum transport delay and ectopic implantation [15, 16]. In
our case, ectopic pregnancy was diagnosed from clinical
and laboratory examinations and evaluations of her condi-
tion. Because of her two previous cesarean sections and the
suspicion of secondary salpingitis by endemic chronic pel-
vic infections we performed medical treatment with MTX.
Primary ovarian ectopic pregnancy is usually seen
among young fertile multipara women who use an IUD
[17]. Berger and Blechner documented that the ratio of
ovarian ectopic pregnancy among women using an IUD
to all ectopic cases is 1:9; its prevalence in the general
population is detected as 1:150 to 200 [16]. Our case had
no history of IUD usage. In the case series of Raziel et al.,
18 of 20 cases of ovarian pregnancy were using an IUD
[14]. The link between IUDs and ovarian pregnancy in fer-
tile patients is worthy of comment. In their study, Lehfeldt
et al. detected that the IUDs prevent uterine implantation
by 99.5 % and tubal implantation by 95.5 %; however,
there is no preventive effect on ovarian implantation [18].
As the definitive diagnosis is made surgically and histo-
pathologically even in patients with early onset, surgical
interventions have both a diagnostic and a therapeutic
value. Because oophorectomy is a radical procedure for
ovarian ectopic pregnancy, consideration should be given
to the patient’s age, fertility, her desire to have further
pregnancies, and the size of the mass; wedge resection can
also be another surgical option.
Medical and conservative treatments have also been in-
troduced in recent years to prevent ovarian tissue loss,
pelvic adhesions and to preserve the patient’s fertility.
These include administration of mifepristone for patients
diagnosed using a transvaginal USG, parenteral prosta-
glandin F2a and MTX treatment for non-ruptured cases
detected with laparoscopy [11, 19]. Pagidas and Frishman
performed MTX treatment for ovarian ectopic cases diag-
nosed using transvaginal USG and achieved healing. They
emphasized that early staged cases diagnosed by transvagi-
nal USG, can benefit from MTX treatment [20]. Di Luigi
et al. also performed and succeeded with multidose MTX
treatment which they administered to a 37-year-old pa-
tient with a history of two previous cesarean sections and
IUD usage; she was diagnosed at 6 weeks of ectopic ovar-
ian pregnancy by use of a transvaginal USG. They empha-
sized that with careful clinical evaluation and transvaginal
examination early staged ovarian ectopic cases can be
treated medically which preserves the normal anatomy
crucial for fertility [21]. A review of the data shows that
MTX treatment is chosen after a clear diagnosis and de-
tection of the localization of ectopic cases by laparoscopy
and therefore laparoscopy is declared to be a supporting
diagnostic procedure [22]. In cases in which the gesta-
tional sac is lower than 30 mm, without fetal cardiac activ-
ity, and less than 6-weeks old, MTX treatment is
supported in particular and is superior to surgery because
it does not disturb fertility [23].
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In our case although she had pelvic fluid of hemorrhagic
character that could have been caused by pelvic rupture, a
clinical evaluation and consideration of her previous oper-
ations led us to treat her medically. Her beta HCG levels
progressively decreased after single dose MTX and she
did not face the risks of further surgery.
Conclusions
Although ovarian ectopic pregnancy is a rare condition,
after careful evaluation, the selection of medical proce-
dures should take into consideration the preservation of
fertility particularly for young patients.
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